Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Ampio Pharmaceuticals, Inc. | tv503365_8k.htm |
Exhibit 16.1
October 4, 2018
Securities and Exchange Commission
Washington, D.C. 20549
Commissioners:
We have read Ampio Pharmaceuticals, Inc.’s statements included under Item 4.01 of its Form 8-K filed on October 4, 2018, and we agree with such statements concerning our firm.
/s/EKS&H LLLP